Concurrent apatinib and local radiation therapy for advanced gastric cancer: A case report and review of the literature

RATIONALE: Apatinib is a novel anti-angiogenic agent targeting vascular endothelial growth factor receptor-2, which is effective in patients with chemotherapy-refractory gastric cancer. There are no reports of concurrent apatinib with local radiation therapy in elderly patients with advanced gastric...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ming, Deng, Weiye, Cao, Xiaoci, Shi, Xiaoming, Zhao, Huanfen, Duan, Zheping, Lv, Bonan, Liu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340464/
https://www.ncbi.nlm.nih.gov/pubmed/28248891
http://dx.doi.org/10.1097/MD.0000000000006241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340464/
https://www.ncbi.nlm.nih.gov/pubmed/28248891
http://dx.doi.org/10.1097/MD.0000000000006241

Ejemplares similares